Watch: European stocks rise on vaccine hopes
European stocks hit an eight-month high on Monday, lifted by stronger-than-expected Chinese factory data, the signing of a new Asia-Pacific trade deal and fresh coronavirus vaccine hopes.
US biotech company Moderna (MRNA) announced on Monday that its COVID-19 vaccine candidate had been 94.5% effective during its third-phase trials of 30,000 participants in the US.
The FTSE 100 (^FTSE) closed 1.7% higher after Modern’s announcement, reaching a five-month high. The DAX (^GDAXI) gained 0.5% in Frankfurt and the CAC 40 (^FCHI) rose 1.7% in Paris. The Europe-wide Stoxx 600 index (^STOXX) gained 1.2%, reaching its highest level in more than eight months.
US stocks also leapt later in the trading day. The S&P 500 (^GSPC) was trading 0.9% higher shortly after European markets closed, while the Dow Jones Industrial Average (^DJI) rose 1.3%, and the Nasdaq (^IXIC) gained 0.5%.
Before Moderna’s announcement, global stocks had already been buoyed by data showing industrial output in China rising quicker than expected by analysts in October, up 6.9% year-on-year. Retail sales came in lower than expected at 4.3% growth, but still marked the fastest annual rate of expansion this year.
Watch: U.S. drugmaker says its COVID-19 vaccine candidate appears to be 94.5% effective
Commodity stocks were among the biggest risers in the UK on hopes of stronger demand, with Glencore (GLEN.L) up 3.1% and Antofagasta (ANTO.L) up 3%. European oil and gas firms on the Stoxx 600 index were up 1.1%, outperforming the 0.7% gains on the wider index, while vaccine hopes lifted travel and leisure stocks.
Meanwhile 15 countries including almost a third of the global population signed the world's largest regional free trade deal on Sunday, the Regional Comprehensive Economic Partnership.
In Asia overnight, Japan’s Nikkei (^N225) rose 2.1%, the Hong Kong Hang Seng (^HSI) rose 0.7%, and the Shanghai Composite (000001.SS) gained 1.1%. South Korea’s KOSPI (^KS11) rose 2%. Meanwhile in Australia, the ASX 200 (^AXJO) gained 1.2%.
Moderna’s announcement comes after similarly encouraging results from another potential coronavirus vaccine trial by Pfizer (PFE) and BioNTech (BNTX) sparked a rally on global markets early last week.
Concerns about the second wave of the pandemic had cooled the mood in Europe towards the end of the week, but virus-hit stocks were among the biggest risers on Monday.